Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TIRTLE trial of tirzepatide in adults with type 1 diabetes and obesity
ACTRN12624000111572Phase 2Completed
- Sponsor
- Garvan Institute of Medical Research
- Start
- May 2024
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised trial in diabetes mellitus type 1 (T1D) comparing Tirzepatide with Placebo (2 arms). Primary endpoint: Weight. Started May 2024; status: completed.
02
Drugs
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on ACTRN12624000111572.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12624000111572.